ID   CDK14_HUMAN             Reviewed;         469 AA.
AC   O94921; A4D1E6; A6NK51; A8WFP6; B4DHG5; B4DNM2; Q75N06; Q75N22;
AC   Q8N764; Q9H3D7; Q9UDR0;
DT   30-AUG-2002, integrated into UniProtKB/Swiss-Prot.
DT   18-APR-2006, sequence version 3.
DT   15-MAR-2017, entry version 164.
DE   RecName: Full=Cyclin-dependent kinase 14;
DE            EC=2.7.11.22;
DE   AltName: Full=Cell division protein kinase 14;
DE   AltName: Full=Serine/threonine-protein kinase PFTAIRE-1;
DE            Short=hPFTAIRE1;
GN   Name=CDK14; Synonyms=KIAA0834, PFTK1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=11313143; DOI=10.1016/S0378-1119(01)00391-2;
RA   Yang T., Chen J.-Y.;
RT   "Identification and cellular localization of human PFTAIRE1.";
RL   Gene 267:165-172(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3).
RC   TISSUE=Brain;
RX   PubMed=10048485; DOI=10.1093/dnares/5.6.355;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Hirosawa M.,
RA   Miyajima N., Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XII.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 5:355-364(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,
RA   Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
RA   Mural R.J., Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   INTERACTION WITH SEPT8.
RX   PubMed=12098780;
RA   Yang T., Gao Y.K., Chen J.Y.;
RT   "KIAA0202, a human septin family member, interacting with hPFTAIRE1.";
RL   Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao 34:520-525(2002).
RN   [9]
RP   INTERACTION WITH YWHAB; YWHAE; YWHAH AND YWHAQ.
RX   PubMed=16775625; DOI=10.1038/sj.cr.7310071;
RA   Gao Y., Jiang M., Yang T., Ni J., Chen J.;
RT   "A Cdc2-related protein kinase hPFTAIRE1 from human brain interacting
RT   with 14-3-3 proteins.";
RL   Cell Res. 16:539-547(2006).
RN   [10]
RP   FUNCTION.
RX   PubMed=16461467; DOI=10.1073/pnas.0507660103;
RA   Tang X., Guilherme A., Chakladar A., Powelka A.M., Konda S.,
RA   Virbasius J.V., Nicoloro S.M., Straubhaar J., Czech M.P.;
RT   "An RNA interference-based screen identifies MAP4K4/NIK as a negative
RT   regulator of PPARgamma, adipogenesis, and insulin-responsive hexose
RT   transport.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:2087-2092(2006).
RN   [11]
RP   FUNCTION, INTERACTION WITH CCDN3 AND CDKN1A, AND MUTAGENESIS OF
RP   LYS-164.
RX   PubMed=17517622; DOI=10.1073/pnas.0703327104;
RA   Shu F., Lv S., Qin Y., Ma X., Wang X., Peng X., Luo Y., Xu B.E.,
RA   Sun X., Wu J.;
RT   "Functional characterization of human PFTK1 as a cyclin-dependent
RT   kinase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:9248-9253(2007).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-95, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [13]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH CCNY.
RX   PubMed=20059949; DOI=10.1016/j.devcel.2009.11.006;
RA   Davidson G., Shen J., Huang Y.L., Su Y., Karaulanov E.,
RA   Bartscherer K., Hassler C., Stannek P., Boutros M., Niehrs C.;
RT   "Cell cycle control of wnt receptor activation.";
RL   Dev. Cell 17:788-799(2009).
RN   [14]
RP   FUNCTION, INTERACTION WITH CCNY, SUBCELLULAR LOCATION, AND MUTAGENESIS
RP   OF LYS-164.
RX   PubMed=19524571; DOI=10.1016/j.febslet.2009.06.010;
RA   Jiang M., Gao Y., Yang T., Zhu X., Chen J.;
RT   "Cyclin Y, a novel membrane-associated cyclin, interacts with PFTK1.";
RL   FEBS Lett. 583:2171-2178(2009).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-95, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-24; SER-78 AND SER-134,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [18]
RP   IDENTIFICATION IN A COMPLEX WITH CAPRIN2; LRP6 AND CCNY.
RX   PubMed=27821587; DOI=10.1074/jbc.M116.744607;
RA   Wang X., Jia Y., Fei C., Song X., Li L.;
RT   "Caprin-2 positively regulates CDK14/Cyclin Y-mediated LRP5/6
RT   constitutive phosphorylation.";
RL   J. Biol. Chem. 291:26427-26434(2016).
RN   [19]
RP   VARIANTS [LARGE SCALE ANALYSIS] ILE-432 AND ARG-463.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Serine/threonine-protein kinase involved in the control
CC       of the eukaryotic cell cycle, whose activity is controlled by an
CC       associated cyclin. Acts as a cell-cycle regulator of Wnt signaling
CC       pathway during G2/M phase by mediating the phosphorylation of LRP6
CC       at 'Ser-1490', leading to the activation of the Wnt signaling
CC       pathway. Acts as a regulator of cell cycle progression and cell
CC       proliferation via its interaction with CCDN3. Phosphorylates RB1
CC       in vitro, however the relevance of such result remains to be
CC       confirmed in vivo. May also play a role in meiosis, neuron
CC       differentiation and may indirectly act as a negative regulator of
CC       insulin-responsive glucose transport.
CC       {ECO:0000269|PubMed:16461467, ECO:0000269|PubMed:17517622,
CC       ECO:0000269|PubMed:19524571, ECO:0000269|PubMed:20059949}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Serine/threonine-protein kinase activity is
CC       promoted by associated cyclins CCDN3 and CCNY and repressed by
CC       CDKN1A.
CC   -!- SUBUNIT: Found in a complex with LRP6, CCNY and CAPRIN2 during
CC       G2/M stage; CAPRIN2 functions as a scaffold for the complex by
CC       binding to CCNY via its N terminus and to CDK14 via its C terminus
CC       (PubMed:27821587). Interacts with CCNY; CCNY mediates its
CC       recruitment to the plasma membrane and promotes phosphorylation of
CC       LRP6 (PubMed:20059949, PubMed:19524571). Interacts with CCDN3 and
CC       CDKN1A (PubMed:17517622). Interacts with SEPT8 (PubMed:12098780).
CC       Interacts with 14-3-3 proteina YWHAB, YWHAE, YWHAH and YWHAQ
CC       (PubMed:16775625). {ECO:0000269|PubMed:12098780,
CC       ECO:0000269|PubMed:16775625, ECO:0000269|PubMed:17517622,
CC       ECO:0000269|PubMed:19524571, ECO:0000269|PubMed:20059949,
CC       ECO:0000269|PubMed:27821587}.
CC   -!- INTERACTION:
CC       P30281:CCND3; NbExp=5; IntAct=EBI-1043945, EBI-375013;
CC       Q8ND76:CCNY; NbExp=7; IntAct=EBI-1043945, EBI-1049189;
CC       P38936:CDKN1A; NbExp=8; IntAct=EBI-1043945, EBI-375077;
CC       P08238:HSP90AB1; NbExp=2; IntAct=EBI-1043945, EBI-352572;
CC       P31946:YWHAB; NbExp=5; IntAct=EBI-1043945, EBI-359815;
CC       P62258:YWHAE; NbExp=3; IntAct=EBI-1043945, EBI-356498;
CC       Q04917:YWHAH; NbExp=3; IntAct=EBI-1043945, EBI-306940;
CC       P27348:YWHAQ; NbExp=3; IntAct=EBI-1043945, EBI-359854;
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Peripheral membrane protein.
CC       Cytoplasm. Nucleus. Note=Recruited to the cell membrane by CCNY.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=O94921-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O94921-2; Sequence=VSP_004803;
CC       Name=3;
CC         IsoId=O94921-3; Sequence=VSP_038762;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Highly expressed in brain, pancreas, kidney,
CC       heart, testis and ovary. Also detected at lower levels in other
CC       tissues except in spleen and thymus where expression is barely
CC       detected. {ECO:0000269|PubMed:11313143}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC
CC       Ser/Thr protein kinase family. CDC2/CDKX subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA74857.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF119833; AAG43234.1; -; mRNA.
DR   EMBL; AB020641; BAA74857.2; ALT_INIT; mRNA.
DR   EMBL; AK289782; BAF82471.1; -; mRNA.
DR   EMBL; AK295086; BAG58127.1; -; mRNA.
DR   EMBL; AK297974; BAG60284.1; -; mRNA.
DR   EMBL; AK316026; BAH14397.1; -; mRNA.
DR   EMBL; AC000057; AAS07411.1; -; Genomic_DNA.
DR   EMBL; AC000059; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC002065; AAM48566.1; -; Genomic_DNA.
DR   EMBL; AC002456; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC002458; AAS07412.1; -; Genomic_DNA.
DR   EMBL; AC006036; AAF19245.1; -; Genomic_DNA.
DR   EMBL; CH236949; EAL24162.1; -; Genomic_DNA.
DR   EMBL; CH471091; EAW76873.1; -; Genomic_DNA.
DR   EMBL; CH471091; EAW76874.1; -; Genomic_DNA.
DR   EMBL; BC136476; AAI36477.1; -; mRNA.
DR   EMBL; BC136477; AAI36478.1; -; mRNA.
DR   EMBL; BC152388; AAI52389.1; -; mRNA.
DR   EMBL; BC152436; AAI52437.1; -; mRNA.
DR   EMBL; BC167152; AAI67152.1; -; mRNA.
DR   EMBL; BC167156; AAI67156.1; -; mRNA.
DR   CCDS; CCDS5619.1; -. [O94921-2]
DR   CCDS; CCDS75626.1; -. [O94921-1]
DR   CCDS; CCDS75627.1; -. [O94921-3]
DR   RefSeq; NP_001274064.1; NM_001287135.1. [O94921-1]
DR   RefSeq; NP_001274065.1; NM_001287136.1. [O94921-3]
DR   RefSeq; NP_001274066.1; NM_001287137.1.
DR   RefSeq; NP_036527.1; NM_012395.3. [O94921-2]
DR   RefSeq; XP_005250495.1; XM_005250438.3. [O94921-3]
DR   RefSeq; XP_005250496.1; XM_005250439.2. [O94921-3]
DR   RefSeq; XP_011514608.1; XM_011516306.2. [O94921-1]
DR   RefSeq; XP_016867809.1; XM_017012320.1. [O94921-3]
DR   RefSeq; XP_016867810.1; XM_017012321.1. [O94921-3]
DR   RefSeq; XP_016867811.1; XM_017012322.1. [O94921-3]
DR   UniGene; Hs.258576; -.
DR   UniGene; Hs.430742; -.
DR   UniGene; Hs.740065; -.
DR   ProteinModelPortal; O94921; -.
DR   SMR; O94921; -.
DR   BioGrid; 111239; 19.
DR   DIP; DIP-39618N; -.
DR   IntAct; O94921; 13.
DR   MINT; MINT-7147554; -.
DR   STRING; 9606.ENSP00000265741; -.
DR   BindingDB; O94921; -.
DR   ChEMBL; CHEMBL6162; -.
DR   GuidetoPHARMACOLOGY; 1967; -.
DR   iPTMnet; O94921; -.
DR   PhosphoSitePlus; O94921; -.
DR   BioMuta; CDK14; -.
DR   EPD; O94921; -.
DR   MaxQB; O94921; -.
DR   PaxDb; O94921; -.
DR   PeptideAtlas; O94921; -.
DR   PRIDE; O94921; -.
DR   DNASU; 5218; -.
DR   Ensembl; ENST00000265741; ENSP00000265741; ENSG00000058091. [O94921-2]
DR   Ensembl; ENST00000380050; ENSP00000369390; ENSG00000058091. [O94921-1]
DR   Ensembl; ENST00000406263; ENSP00000385034; ENSG00000058091. [O94921-3]
DR   GeneID; 5218; -.
DR   KEGG; hsa:5218; -.
DR   UCSC; uc003uky.4; human. [O94921-1]
DR   CTD; 5218; -.
DR   DisGeNET; 5218; -.
DR   GeneCards; CDK14; -.
DR   HGNC; HGNC:8883; CDK14.
DR   HPA; HPA015267; -.
DR   MIM; 610679; gene.
DR   neXtProt; NX_O94921; -.
DR   OpenTargets; ENSG00000058091; -.
DR   PharmGKB; PA33221; -.
DR   eggNOG; KOG0594; Eukaryota.
DR   eggNOG; ENOG410XPP3; LUCA.
DR   GeneTree; ENSGT00790000122986; -.
DR   HOVERGEN; HBG014652; -.
DR   InParanoid; O94921; -.
DR   KO; K08821; -.
DR   OMA; LQCFPKN; -.
DR   OrthoDB; EOG091G0CH0; -.
DR   PhylomeDB; O94921; -.
DR   TreeFam; TF106508; -.
DR   SignaLink; O94921; -.
DR   SIGNOR; O94921; -.
DR   ChiTaRS; CDK14; human.
DR   GeneWiki; PFTK1; -.
DR   GenomeRNAi; 5218; -.
DR   PRO; PR:O94921; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000058091; -.
DR   CleanEx; HS_PFTK1; -.
DR   ExpressionAtlas; O94921; baseline and differential.
DR   Genevisible; O94921; HS.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0000308; C:cytoplasmic cyclin-dependent protein kinase holoenzyme complex; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0030332; F:cyclin binding; IPI:UniProtKB.
DR   GO; GO:0004693; F:cyclin-dependent protein serine/threonine kinase activity; IMP:UniProtKB.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0000086; P:G2/M transition of mitotic cell cycle; IDA:UniProtKB.
DR   GO; GO:0060828; P:regulation of canonical Wnt signaling pathway; IDA:UniProtKB.
DR   GO; GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cell cycle; Cell division;
KW   Cell membrane; Complete proteome; Cytoplasm; Kinase; Membrane;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Serine/threonine-protein kinase; Transferase;
KW   Wnt signaling pathway.
FT   CHAIN         1    469       Cyclin-dependent kinase 14.
FT                                /FTId=PRO_0000086506.
FT   DOMAIN      135    419       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     141    149       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE    256    256       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING     164    164       ATP. {ECO:0000305}.
FT   MOD_RES      24     24       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      78     78       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      95     95       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195}.
FT   MOD_RES     134    134       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1     46       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:10048485}.
FT                                /FTId=VSP_038762.
FT   VAR_SEQ       1     41       MCDLIEPQPAEKIGKMKKLRRTLSESFSRIALKKDDTTFDE
FT                                -> MHGYFGCNAAAEPGYSAFVGTPQ (in isoform
FT                                2). {ECO:0000303|PubMed:10048485,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_004803.
FT   VARIANT     432    432       M -> I (in an ovarian mucinous carcinoma;
FT                                somatic mutation; dbSNP:rs773301216).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_046765.
FT   VARIANT     463    463       S -> R (in dbSNP:rs35643773).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_046766.
FT   MUTAGEN     164    164       K->R: Abolishes protein kinase activity.
FT                                {ECO:0000269|PubMed:17517622,
FT                                ECO:0000269|PubMed:19524571}.
FT   CONFLICT      8      8       Q -> R (in Ref. 3; BAG60284).
FT                                {ECO:0000305}.
FT   CONFLICT    158    158       G -> W (in Ref. 1; AAG43234).
FT                                {ECO:0000305}.
SQ   SEQUENCE   469 AA;  53057 MW;  32CF9B9B7BD9CE0E CRC64;
     MCDLIEPQPA EKIGKMKKLR RTLSESFSRI ALKKDDTTFD EICVTKMSTR NCQGMDSVIK
     PLDTIPEDKK VRVQRTQSTF DPFEKPANQV KRVHSENNAC INFKTSSTGK ESPKVRRHSS
     PSSPTSPKFG KADSYEKLEK LGEGSYATVY KGKSKVNGKL VALKVIRLQE EEGTPFTAIR
     EASLLKGLKH ANIVLLHDII HTKETLTLVF EYVHTDLCQY MDKHPGGLHP DNVKLFLFQL
     LRGLSYIHQR YILHRDLKPQ NLLISDTGEL KLADFGLARA KSVPSHTYSN EVVTLWYRPP
     DVLLGSTEYS TCLDMWGVGC IFVEMIQGVA AFPGMKDIQD QLERIFLVLG TPNEDTWPGV
     HSLPHFKPER FTLYSSKNLR QAWNKLSYVN HAEDLASKLL QCSPKNRLSA QAALSHEYFS
     DLPPRLWELT DMSSIFTVPN VRLQPEAGES MRAFGKNNSY GKSLSNSKH
//
